3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Myeloid
1
Conditions
Polycystic Ovary Syndrome
4
Obesity
4
Breast Neoplasms
4
Ovarian Diseases
2
Ovarian Cysts
2
Motor Activity
2
Hereditary Breast and Ovarian Cancer Syndrome
2
Cardiovascular Diseases
2
Thyroid Neoplasms
1
Thrombocythemia, Essential
1
Smoldering Multiple Myeloma
1
Primary Myelofibrosis
1
Polycythemia Vera
1
Overweight
1
Neoplasms
1
Myocardial Infarction
1
Myeloproliferative Disorders
1
Multiple Myeloma
1
Multiple Endocrine Neoplasia Type 1
1
Monoclonal Gammopathy of Undetermined Significance
1
Metabolic Syndrome
1
Intermittent Fasting
1
Inflammation
1
Growth Hormone-Secreting Pituitary Adenoma
1
Fibrosis
1
Feeding Behavior
1
Diabetes Mellitus
1
Cognitive Dysfunction
1
Carcinoma, Hepatocellular
1
Angina, Unstable
1
Interventions
Peripheral Blood Stem Cell Transplantation
4
fludarabine phosphate
3
Tacrolimus
3
Methotrexate
3
Busulfan
3
Mycophenolic Acid
2
Filgrastim
2
Cyclophosphamide
2
Antilymphocyte Serum
2
merphos
1
Whole-Body Irradiation
1
Resistance Training
1
Pharmacogenomic Testing
1
Oxycodone
1
Ondansetron
1
Mutation
1
Music Therapy
1
Moxifloxacin
1
Morphine
1
Methadone
1
Massage
1
Fluorescent Antibody Technique
1
Flow Cytometry
1
Endoscopy, Digestive System
1
Diet, Mediterranean
1
Diagnosis
1
Cytogenetic Analysis
1
Cyclosporine
1
Ciprofloxacin
1
Aprepitant
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Thrombocythemia, Essential
×
Diet, Mediterranean
×
Clear all
NCT03907436
2020-03-24
NUTRIENT
University of California, Irvine
Phase NA
Completed
30 enrolled